SPONSORED – Neuropathy is becoming a bigger problem for more people than ever before. If you`re suffering from stabbing pain, ...

Find Therapeutics has dosed the first subject in a Phase I trial of FTX-101 as a potential treatment for chronic optic ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Peripheral neuropathy, a condition affecting millions of people worldwide, can cause chronic pain, numbness, and weakness, ...

At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...

Pharma titan AstraZeneca has announced that its Wainzua nerve damage treatment has been recommended for approval in the EU.

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s new drug, Wainzua, has been recommended for approval in the EU for treating ...

Peripheral neuropathy is a complex and often debilitating condition that affects millions of people worldwide. Research estimates around 10% of the general population experiences some form of ...

(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...